A Study on the Effects of Breathing Exercises and Aerobic Exercise on the Health of Men in Drug Rehabilitation
A Study on the Effects of 8 Weeks of Resistance and Respiratory Training Combined With Aerobic Exercise on Physical Health and Quality of Life in Male Drug Rehabilitation Patients
1 other identifier
interventional
90
1 country
1
Brief Summary
This study aims to investigate the effects of an 8-week combined exercise program on male individuals in drug rehabilitation. The program integrates resistance-based breathing training with aerobic exercise. The investigators seek to determine whether this combined exercise program is more effective than a single form of exercise in improving participants' physical health and quality of life. The primary research questions to be addressed include: Does this combined exercise program produce better results than single-form training (resistance-based breathing training or aerobic exercise performed separately) in improving physiological indicators such as cardiopulmonary function and muscle strength in male individuals in drug rehabilitation? Does this combined exercise program yield greater benefits than single-form training in reducing anxiety and depression and improving quality of life among men in drug rehabilitation? This study will conduct a randomized controlled trial. Researchers will compare three different intervention groups-the combined training group, the resistance-breathing training group, and the aerobic exercise group-to verify the potential advantages of the combined program over single-form exercise. Participants will: Complete an 8-week exercise intervention, consisting of three sessions per week, each lasting approximately 40 minutes, under professional guidance and supervision. Undergo comprehensive assessments before and after the intervention, including cardiopulmonary function tests, body composition analysis, and questionnaires on mental health and quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2026
CompletedFirst Submitted
Initial submission to the registry
April 28, 2026
CompletedFirst Posted
Study publicly available on registry
May 18, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 10, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2026
ExpectedMay 18, 2026
April 1, 2026
2 months
April 28, 2026
May 11, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Quality of Life Scale for Drug Addicts
Minimum score: 41, Maximum score: 205.Higher scores indicate worse quality of life and more severe impairment in physical, psychological, social, and withdrawal-related symptoms.
Baseline (Week 0), after the intervention (Week 9)
6-Minute Walk Test
The maximum distance a subject can cover in 6 minutes while walking at maximum speed along a 30-meter flat corridor. This test is used to assess cardiopulmonary function and exercise endurance during submaximal exercise.
Baseline (Week 0), after the intervention (Week 9)
Secondary Outcomes (4)
BMI
Baseline (Week 0), after the intervention (Week 9)
Body Composition
Baseline (Week 0), after the intervention (Week 9)
Symptom Checklist-90
Baseline (Week 0), after the intervention (Week 9)
Vital Capacity
Baseline (Week 0), after the intervention (Week 9)
Other Outcomes (8)
Blood pressure
Baseline (Week 0), after the intervention (Week 9)
Oxygen Saturation
Baseline (Week 0), after the intervention (Week 9)
Resting heart rate
Baseline (Week 0), after the intervention (Week 9)
- +5 more other outcomes
Study Arms (3)
Resistance Breathing Training Group
EXPERIMENTALUse a resistance breathing trainer and follow a progressive resistance training regimen, starting with low resistance and gradually increasing the intensity based on individual tolerance.
Aerobic Exercise Group
EXPERIMENTALThis session features moderate-intensity aerobic exercise, with intensity maintained at 60-70% of maximum heart rate, and includes a warm-up, main workout, and cool-down.
Joint Training Group
EXPERIMENTALAfter the warm-up, start with 15 minutes of resistance breathing exercises, followed by 15 minutes of aerobic exercise, and then five minutes of stretching.
Interventions
Warm-up (5 minutes) → Threshold resistance breathing trainer (30 minutes) → Cool-down stretches (5 minutes).During joint training, each session lasts 15 minutes.
Warm-up (5 minutes) → Main exercise (30 minutes, at 65%-85% of maximum heart rate or a Borg RPE score of 12-14) → Cool-down and stretching (5 minutes).During joint training sessions, each training session lasts 15 minutes.
Eligibility Criteria
You may qualify if:
- Male, aged 18 to 50 years, able to understand and comply with the study protocol
- Meets the DSM-5 diagnostic criteria for substance use disorder; in rehabilitation for ≥1 month; withdrawal symptoms are stable (confirmed by medical staff)
- No severe cardiovascular/cerebrovascular disease, respiratory disease, musculoskeletal injury, or other contraindications to physical activity
- Basic reading and writing ability to independently complete questionnaire assessments
- Voluntarily signed informed consent and committed to complying with the 8-week training program
You may not qualify if:
- Presence of contraindications to exercise (e.g., recent fracture, severe arrhythmia, uncontrolled hypertension)
- Concurrent severe mental disorders (e.g., schizophrenia, acute depressive episode) or currently receiving unstable psychiatric medication
- Currently participating in other intervention studies or clinical trials
- Expected training compliance rate \<70% (e.g., unable to complete the 8-week intervention due to transfer or disciplinary action)
- Unable to continue participation for personal reasons (e.g., early discharge, serious disciplinary violation)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Yongtingli
Luzhou, 646000, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Graduate student
Study Record Dates
First Submitted
April 28, 2026
First Posted
May 18, 2026
Study Start
April 1, 2026
Primary Completion
June 10, 2026
Study Completion (Estimated)
June 30, 2026
Last Updated
May 18, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share